Medical Device News Magazine

Augmedix Launches Industry’s First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments

Following incubation with HCA Healthcare EDs, Augmedix announces the general availability of Augmedix Go in emergency departments

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Augmedix

Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced the general availability of Augmedix Go for emergency departments (EDs), marking the launch of the industry’s first fully-automated, generative AI (GenAI) powered medical documentation product for EDs across the country.

HCA Healthcare

The launch incorporates learnings from a pilot program with HCA Healthcare (NYSE: HCA), one of the nation’s leading healthcare providers. As part of the pilot, ED physicians in four HCA Healthcare hospitals utilized Augmedix Go to automate medical documentation, with the product instantaneously drafting their medical notes from patient visits.

Michael J. Schlosser, MD, MBA, FAANS, SVP, Care Transformation and Innovation, HCA Healthcare

“The work we’ve done on Augmedix Go in the ED demonstrates how the Augmedix team has worked to build a strong, long-term relationship with HCA Healthcare and provide us high-quality, successful deployments.”

Augmedix Go aims to improve the patient experience at the point of care, increase productivity by improving documentation quality, reduce the cognitive burden of note taking by providers, and shorten chart closure time. The clinician feedback and data garnered from the pilot supported Augmedix Go’s ability to achieve these objectives.

Veronica L. Cassese Klasko, MHSc, MMS, PA-C, physician assistant at HCA Florida Trinity Hospital

“Using Augmedix allowed me to spend more time with my patients and less time in front of my computer. I was also able to essentially eliminate charting after my shift was over, which makes a huge difference.

Augmedix’s extensive experience in acute care settings with its other products helped it to fine-tune its AI technology to address the unique challenges of clinical documentation in the ED such as multiple interactions, documenting medical decision making, re-evaluations and progress updates. The workflow in the ED requires technology that can accommodate complex conversations and a plurality of recordings capturing multiple, non-sequential interactions with a single patient. All of which occurs in a typically noisy environment.

Augmedix Go offers clinicians the option to engage with patients in a hands-free environment by pairing the mobile app, stored in their lab coat pocket, with a bluetooth mic, to seamlessly capture patient conversations. Patients consent to the use of Augmedix at a 99% acceptance rate. Clinicians reported positive feedback on the audio capture, note quality, and AI accuracy, even in these challenging environments.

“Despite how loud it was in the ED, Augmedix got the note content right,” said Michael Borunda, M.D., ED Director at HCA Florida Trinity Hospital. “After careful review, I had no edits and was able to send my note straight to the EHR.”

Augmedix utilizes both proprietary fine-tuned large language models (LLMs) and industry-leading foundational LLMs, including Google Cloud’s MedLM’s suite of medically-tuned models. These AI models are utilized across different specialties and sections of the note to deliver high quality medical documentation. Augmedix Go’s user interface exposes the principal steps in its note creation process to help instill trust among clinicians.

“The launch of Augmedix Go in the ED represents our unwavering commitment to develop solutions for health systems that improve their workflows. Our agility and flexible architecture, exhibited by our broad product suite and open network platform, help us address the complex and varying needs of clinicians and providers,” said Manny Krakaris, CEO of Augmedix. “We have built a sophisticated platform designed to enable clinicians to be present with their patients while trusting that Augmedix technology is doing administrative work unobtrusively in the background.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”